EIDD-1931(NHC)
98%
- Product Code: 65308
CAS:
3258-02-4
| Molecular Weight: | 259.218 g./mol | Molecular Formula: | C₉H₁₃N₃O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
EIDD-1931, also known as NHC, is primarily studied for its antiviral properties, particularly in the treatment of RNA virus infections. It has shown promise in inhibiting the replication of viruses such as influenza, Ebola, and coronaviruses, including SARS-CoV-2. The compound works by introducing errors into the viral RNA during replication, effectively reducing the virus's ability to spread and cause disease. Its potential application extends to both therapeutic and prophylactic uses, making it a candidate for treating active infections and preventing viral outbreaks. Research is ongoing to evaluate its efficacy, safety, and potential use in combination with other antiviral therapies.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white Solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿32,000.00 |
+
-
|
| 0.010 | 10-20 days | ฿51,000.00 |
+
-
|
| 0.050 | 10-20 days | ฿89,990.00 |
+
-
|
EIDD-1931(NHC)
EIDD-1931, also known as NHC, is primarily studied for its antiviral properties, particularly in the treatment of RNA virus infections. It has shown promise in inhibiting the replication of viruses such as influenza, Ebola, and coronaviruses, including SARS-CoV-2. The compound works by introducing errors into the viral RNA during replication, effectively reducing the virus's ability to spread and cause disease. Its potential application extends to both therapeutic and prophylactic uses, making it a candidate for treating active infections and preventing viral outbreaks. Research is ongoing to evaluate its efficacy, safety, and potential use in combination with other antiviral therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :